E-Mail
IMAGE: A fluorescent microscope image of a thin section of a human kidney stone reveals a complex history of crystal growth layering, fracturing, dissolution and recrystallization. view more
Credit: Image courtesy of Mayandi Sivaguru, University of Illinois
CHAMPAIGN, Ill. Advanced microscope technology and cutting-edge geological science are giving new perspectives to an old medical mystery: How do kidney stones form, why are some people more susceptible to them and can they be prevented?
In a new paper published in the journal
Nature Reviews Urology, researchers from the University of Illinois Urbana-Champaign, Mayo Clinic and other collaborators described the geological nature of kidney stones, outlined the arc of their formation, established a new classification scheme and suggested possible clinical interventions.
Sensyne Health Signs Strategic Research Agreement with the Colorado Center for Personalized Medicine
New agreement covering 7.3 million patients brings Sensyne’s combined total dataset of anonymised and de-identified patient data for medical research to 18.2 million patients
Second U.S. Strategic Research Agreement by clinical AI pioneer Sensyne to enable the ethical application of clinical AI to improve patient care and accelerate medical research
Oxford, U.K, and Dover, Delaware, USA 24 May 2021: Sensyne Health plc (LSE: SENS) (“Sensyne” or the “Company” or the “Group”), the Clinical AI company, today announces that it has signed its second Strategic Research Agreement (“SRA”) in the U.S. with the Colorado Center for Personalized Medicine (“CCPM”), a partnership between non-profit health system UCHealth and the University of Colorado Anschutz Medical Campus.
Sensyne Health signs second US research agreement
All data supplied to Sensyne for research will be anonymised by CCPM and will remain in the US. The provision of the data will operate under an agreed set of data processing procedures
Sensyne Health PLC (LON:SENS) has signed a strategic research agreement with the Colorado Center for Personalized Medicine (CCPM).
It is the second strategic research agreement in the US signed by Sensyne, which uses artificial intelligence (AI) technology to ethically use mass patient data to support medical research; the company announced a similar agreement last Friday with St Luke s University Health Network in Pennsylvania.
Sensyne Health forms clinical AI alliance with CCPM in US 24 May 2021 (Last Updated May 24th, 2021 12:38)
Sensyne Health signs clinical AI research partnership with Colorado Center for Personalized Medicine.
Share Article
Sensyne signs clinical AI partnerships to fast-track medical research. Credit: Sensyne Health plc.
Sensyne Health, a UK-based clinical artificial intelligence (AI) company, has entered a strategic research agreement with the Colorado Center for Personalized Medicine (CCPM) in the US.
The partners will use clinical AI research for better patient care and expediting medical research.
Sensyne noted that the move is part of its goal to create a health data platform with industrial scale and strong protection of patient data.
Follow John on:
A look at some of the major movers in London on Monday
OnTheMarket PLC (LON:OTMP) advanced 6.1% to 87.5p after it announced a commercial partnership with rental platform Canopy.
The partnership will enable OnTheMarket to provide its agent customers with free comprehensive tenant referencing, including employment and landlord references, for all tenancy applications.
Canopy s RentPassport includes Experian credit history, adverse financial history and provides verification of identity and address along with Know Your Customer, Anti Money Laundering and other information. The Canopy and OnTheMarket rental platform will be live in July 2021.
3.30pm: Synairgen wanted after its inhaled interferon beta shows potential antiviral activity